Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Neurourology and Urodynamics|December 22, 2009
Neurologic fecal incontinenceJ J Wyndaele, A Kovindha, Y Igawa, et al.
Neurourology and Urodynamics|December 22, 2009
Neurologic urinary incontinenceJ J Wyndaele, A Kovindha, H Madersbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA)B Hanke, C Riedel, S Lampert, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stageA V D'Amico, R Whittington, S B Malkowicz, et al.
Progress in Clinical and Biological Research|January 1, 1994
Correlation between urinary flow rate, voided volume, and patient age in a community-based populationJ E Oesterling, C J Girman, L A Panser, et al.
The Journal of Urology|August 24, 1999
Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivoA Nehra, M T Gettman, M Nugent, et al.
Urology|May 30, 2001
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based surveyJ N Liberman, T L Hunt, W F Stewart, et al.
Journal of the American Chemical Society|June 9, 2021
Synthesis of Pyrroles via Consecutive 6π-Electrocyclization/Ring-Contraction of SulfiliminesFranz-Lucas Haut, Niklas J Feichtinger, Immanuel Plangger, et al.
Cancer|January 28, 1998
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.
Pageof 20